MKI67 and breast ductal adenocarcinoma: Univariate logistic regression analysis showed that patients who had stage II disease, cT1 tumors, ductal carcinoma, TNBC subtype, TCbHP/THP/AC-THP chemotherapy plan, 6/8 chemotherapy cycles and high expression of Ki-67 were more likely to achieve pCR.